BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10064593)

  • 1. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.
    Rosário M; Paterson HF; Marshall CJ
    EMBO J; 1999 Mar; 18(5):1270-9. PubMed ID: 10064593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
    Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TC21 causes transformation by Raf-independent signaling pathways.
    Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
    Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.
    Graham SM; Cox AD; Drivas G; Rush MG; D'Eustachio P; Der CJ
    Mol Cell Biol; 1994 Jun; 14(6):4108-15. PubMed ID: 8196649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
    Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R; Chan AM; Miki T; Aaronson SA
    Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
    Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
    Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.
    Rong R; He Q; Liu Y; Sheikh MS; Huang Y
    Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways regulating TC21-induced tumorigenesis.
    Erdogan M; Pozzi A; Bhowmick N; Moses HL; Zent R
    J Biol Chem; 2007 Sep; 282(38):27713-20. PubMed ID: 17656362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade.
    Porras A; Santos E
    Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S43-51. PubMed ID: 8680477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6.
    Quilliam LA; Castro AF; Rogers-Graham KS; Martin CB; Der CJ; Bi C
    J Biol Chem; 1999 Aug; 274(34):23850-7. PubMed ID: 10446149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane recruitment of Raf-1 is not the only function of Ras in Raf-1 activation.
    Tamada M; Hu CD; Kariya K; Okada T; Kataoka T
    Oncogene; 1997 Dec; 15(24):2959-64. PubMed ID: 9416839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
    Agarwal S; Corbley MJ; Roberts TM
    Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.